Latest News about SNY
Recent news which mentions SNY
7 Blue-Chip Stocks to Buy as a New Bull Market Emerges
January 26, 2023
Tags
NYSE:DEO,NYSE:SON,NYSE:D,NASDAQ:SNY,NYSE:EPD,NASDAQ:JD,NYSE:PM,NYSE:MO,NYSE:BTI
BTI
Stocks to Buy
From InvestorPlace
Wall Street Thinks These 2 Blazing Healthcare Stocks Could Have 21% to 30% Upside in 2023
January 23, 2023
From Motley Fool
Johnson & Johnson Cuts Production, Ends Contracts For Not So Successful COVID-19 Shot
January 13, 2023
From Benzinga
Drug companies plan to raise prices on vital medicines to fund R&D, but they already spend more on shareholder returns
January 13, 2023
From MarketWatch
From Benzinga
What This Drug News Could Mean for Sanofi Shareholders
January 08, 2023
From Motley Fool
5 Top Pharma Stocks of 2022 to Buy for the Long Haul
January 06, 2023
From InvestorPlace
From Benzinga
Could This Drug News Give a Lift to Eli Lilly Stock?
January 01, 2023
From Motley Fool
3 Medical Dividend Stocks That Hit the Sweet Spot
December 26, 2022
From Motley Fool
After Five Years Of Collaboration, Sanofi & Innate Pharma Expand Oncology Pact With Additional Programs
December 19, 2022
From Benzinga
2 Best Biotech Stocks to Buy Right Now
December 16, 2022
From Motley Fool
Regeneron-Sanofi's Dupixent Wins European Approval For Prurigo Nodularis
December 15, 2022
From Benzinga
These Biotech Stocks Are the Nasdaq's Big Wednesday Winners
December 14, 2022
From Motley Fool
Why Is Kymera Therapeutics (KYMR) Stock Up 20% Today?
December 14, 2022
From InvestorPlace
From Benzinga
Horizon Therapeutics (HZNP) Stock Pops on HUGE Amgen Deal
December 12, 2022
From InvestorPlace
From Benzinga
Two Down With Sanofi Bowing Out From Horizon Buyout Talks, Amgen Agrees To Buy For $116.5/Share
December 12, 2022
From Benzinga
Amgen reportedly in talks to buy Horizon Therapeutics
December 12, 2022
From MarketWatch
Will This Potential Approval Be a Winner for Sanofi's Shareholders?
December 09, 2022
From Motley Fool
France Health Body Advises Unfavorable Opinion Regarding Valneva's COVID-19 Vaccine
December 08, 2022
From Benzinga
This Monster Dividend Stock Isn't Done Growing
December 08, 2022
From Motley Fool
Revolution Medicines Regains Global Rights To Mid-Stage Cancer Program As Sanofi Terminates Collaboration
December 08, 2022
From Benzinga
Fusion Fuel (HTOO) Stock Is Up 11% on HUGE Deal News
December 07, 2022
From InvestorPlace
Why Is TransCode Therapeutics (RNAZ) Stock Up 148% Today?
December 07, 2022
From InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.